B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

MDM4

MOLECULAR TARGET

MDM4 regulator of p53

UniProt: O15151NCBI Gene: 419451 compounds

MDM4 (MDM4 regulator of p53) is targeted by 51 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting MDM4

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Digoxin1.614
2Calcimycin1.393
3cycloheximide1.393
4Digitoxigenin 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide.1.393
5Niclosamide1.393
6Tubercidin1.393
7Anisomycin1.102
8Astemizole Antihistamine drug now withdrawn from1.102
9Azacitidine1.102
10Azacitidine1.102
11Chlorhexidine1.102
12Ciclopirox1.102
13Cladribine1.102
14Colchicine1.102
15colchine1.102
16Cytarabine1.102
17Demecolcine1.102
18Digoxigenin 3 beta,12 beta,14-Trihydroxy-5 beta-card-20(22)-enolide.1.102
19Fluspirilene1.102
20gedunin1.102
21Hexachlorophene1.102
22lidoflazine1.102
23Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of1.102
24Nisoldipine1.102
25Nocodazole Nocodazole is1.102
26Ouabain1.102
27paxilline1.102
28Podophyllotoxin1.102
29rafoxanide1.102
30streptonigrin1.102
31Strophanthidin 3 beta,5,14-Trihydroxy-19-oxo-5 beta-card-20(22)-enolide.1.102
32Trifluridine1.102
33tyrphostin 91.102
34vinblastine sulfate1.102
35Methylene Blue0.691
36Sertraline0.691
37Simvastatin0.691
38Ursolic Acid0.691
39Methotrexate0.691
40Aripiprazole0.691
41cardamonin0.691
42dihydrorotenone0.691
43Dinitrochlorobenzene0.691
44Lovastatin0.691
45Melphalan0.691
46Oxyphenbutazone0.691
47propionylpromazine hydrochloride0.691
48sp6001250.691
49Spironolactone0.691
50Thioridazine0.691

Showing top 50 of 51 compounds. Use the BiohacksAI search to explore all MDM4 modulators.

About MDM4 as a Drug Target

MDM4 (MDM4 regulator of p53) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 51 compounds with documented MDM4 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

MDM4 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.